“…Most only considered immediate costs: per test [24,26,32,36,[94][95][96], per case detected (usually cases of risk-factor, not amblyopia) [25,56,57,63,70,83,95,96], or to diagnosis [56,57,63,70,83,95,96]. Longer-term costs were more disparate: savings made by re-screening [57], screening service cost [58,63,71], total cost to a state [73], additional costs of adding photoscreening to established services [24,31,56,65], costs of different types of follow-up [57], costs to third-party providers [24,57,63,70], cost for detection plus follow-up [57,58,70], lifetime costs e.g. Quality Adjusted Life Years (QALYs) [20,31,71].…”